Navigation Links
Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
Date:9/8/2010

ST. LOUIS, Sept. 8 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) highlighted significant new additions to the body of evidence demonstrating exceptional clinical outcomes achieved with its Niobe® Magnetic Navigation System in ventricular tachycardia (VT) ablation.

At the European Cardiology Society Annual Congress in Stockholm last week, the research team led by Dr. Tamas Szili-Torok from the Erasmus Medical Center in Rotterdam presented the first comparative trial in a prospective study of 64 consecutive VT patients, comparing Stereotaxis VT ablation to conventional, non-magnetic ablation.  Acute success was achieved in 97% of the Stereotaxis VT ablation group versus 81% of the manual ablation group.  Patients in the Stereotaxis VT group averaged 50% less x-ray exposure, and after a year, only 14% VT recurrence, versus a 50% recurrence rate among manual ablation patients.  A remarkable 25% reduction in total procedure time was achieved in the Stereotaxis VT group compared to the manual group.

There were no major complications in the Stereotaxis VT group compared to one death in the non-Stereotaxis group, representing a 4% major complication rate.

"The use of Stereotaxis offers major advantages for the ablation of VT," said Dr. Szili-Torok. "We have adopted a 100% utilization rule for our Stereotaxis lab for cardiac arrhythmias due to the significant benefits for our patients as well as for us as operators."

Further, Dr. Arash Arya and colleagues from the University of Leipzig Heart Center in Leipzig, Germany published data from a series of 30 consecutive patients who were suffering from "VT storm," which is three or more VT episodes in a 24 hour period that trigger a shock treatment from an implanted defibrillator device.  While treating VT Storm is extremely challenging, Dr. Arya reported that 70% of the patients
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Stereotaxis Announces Second Quarter 2010 Earnings Release Date and Conference Call
2. New Data Demonstrate Safety, Efficacy of Stereotaxis for Patients with AFIB, VT and Congenital Defects
3. Stereotaxis and Siemens Promote Integrated Odyssey(TM) Solutions
4. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
5. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
6. Stereotaxis Installs First System in Taiwan
7. Stereotaxis System Procedure Featured on NBCs The TODAY Show
8. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
9. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
10. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
11. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Reportlinker.com announces that ... its catalogue: Portugal Pharmaceuticals and ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes 3 ... Faster-than-expected economic growth last quarter has led us ... upwards. As forecast previously, BMI expects ...
(Date:7/28/2014)... , July 28, 2014  UBM Medica US ... leading online community for medical imaging professionals, explored the ... value-based payment models . The shift from ... how the radiologist,s reimbursement is determined in the ... insight from leaders in the field, who recognized the ...
(Date:7/28/2014)... 2014  MedSpring Urgent Care, an Austin -based ... Lamar Blvd., Austin, TX 78704 on Saturday, ... the southeast corner of Barton Springs Rd. and S. ... 9 p.m. daily, including weekends and holidays. With existing ... Austin , Anderson Mill , Cedar Park ...
Breaking Medicine Technology:Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Diagnostic Imaging Delves into Measuring the Radiologist's Value 2MedSpring Urgent Care opens Barton Springs walk-in clinic in Austin, TX 2
... May 17 Xenon Pharmaceuticals Inc. is pleased to announce ... Vice President, Research and Development. , ... "We are delighted to welcome Tarek to the Xenon team," ... world-class R&D executive whose experience in discovering products, a number of which ...
... TAI,AN, China , May ... CBPO ) ("China Biologic" or the "Company"), ... the People,s Republic of,China ("PRC"), operating through ... Ltd. ("Taibang") and Guiyang Dalin,Biologic Technologies Co., Ltd. ...
Cached Medicine Technology:Xenon Announces Appointment of EVP, Research & Development 2China Biologic Products Announces First Quarter 2010 Results 2China Biologic Products Announces First Quarter 2010 Results 3China Biologic Products Announces First Quarter 2010 Results 4China Biologic Products Announces First Quarter 2010 Results 5China Biologic Products Announces First Quarter 2010 Results 6China Biologic Products Announces First Quarter 2010 Results 7China Biologic Products Announces First Quarter 2010 Results 8China Biologic Products Announces First Quarter 2010 Results 9China Biologic Products Announces First Quarter 2010 Results 10China Biologic Products Announces First Quarter 2010 Results 11China Biologic Products Announces First Quarter 2010 Results 12China Biologic Products Announces First Quarter 2010 Results 13China Biologic Products Announces First Quarter 2010 Results 14China Biologic Products Announces First Quarter 2010 Results 15China Biologic Products Announces First Quarter 2010 Results 16China Biologic Products Announces First Quarter 2010 Results 17China Biologic Products Announces First Quarter 2010 Results 18
(Date:7/29/2014)... July 29, 2014 Tucson-based company ... employer’s benefits package, or health and wellness program, called ... while providing an effective way for employees to use ... of the program, employees specify the amount of each ... , An employer benefits from offering a 401(play)™ plan ...
(Date:7/29/2014)... Guests at Napa Valley's quintessential luxury resort, ... new sleep experience. The top of each luxurious resort bed ... , These expertly crafted, 100% Egyptian cotton white duvets and ... yet upon closer look, words are woven in the linens ... breathe. , Intentional breathing and visualization are keys ...
(Date:7/29/2014)... 2014 In his latest blog post at ... CEO Per Wickstrom has listed 6 ways to light the ... creativity and avoid complacency, but for some it’s a losing ... progressive and powerful ways to help employees get to the ... as a whole.” , According to Per Wickstrom, 6 ways ...
(Date:7/29/2014)... Battle Creek, MI (PRWEB) July 29, 2014 ... treatment program that gets clients off to a great start ... believe in, was a proud sponsor of the National Cherry ... City, MI. , The concert, which was co-sponsored by Miller ... Collective Soul take to the Pepsi Bay Side Music Stage ...
(Date:7/29/2014)... 29, 2014 Launched in 2012 by ... surpassed 20,000 hangovers earlier this year at its Vegas ... expansion and the publication of research data related to ... practice. , The only licensed medical practice dedicated to ... launched in 2012 and treated thousands of patients within ...
Breaking Medicine News(10 mins):Health News:Outski launches 401(play)™ Plan to Employers as Part of an Employee Benefit / Health and Wellness Program 2Health News:Auberge Du Soleil Offers INTENTIONS™ by Peacock Alley on Guests' Beds Providing a Unique Sleep Experience 2Health News:Per Wickstrom’s Latest Blog Post Lists 6 Ways to Light the “Fire” in Employees 2Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
... Meeting of the American Political Science Association (APSA) will ... Metro Toronto Convention Centre, the InterContinental Toronto Centre, and ... time in its history that the meeting has been ... is the world,s largest gathering of political scientists; almost ...
... , ... its outreach to its current and future patients by its recent launch of accounts ... ... 2009 -- KoolDocs.com, the web,s leading resource for online medical consultations, diagnoses, prescriptions, and ...
... SCHAUMBURG, Ill., Aug. 27 Sagent Pharmaceuticals, Inc., ... has launched fluconazole injection in premix bags. IMS Health estimates ... Sagent will begin marketing and shipping fluconazole bags immediately. , ... again exemplified in our new fluconazole offering, the most recent ...
... , DES PLAINES, Ill. and NEW YORK, ... an agreement with Pfizer Inc to develop a molecular diagnostic test ... presence of gene rearrangements. Pfizer has developed a novel investigational ... many cancers. To be eligible to receive Pfizer,s oral therapy, ...
... , PRINCETON, N.J., Aug. 27 ... rare form of hemophilia are coming together at educational summits ... the Center for Biomedical Continuing Education (CBCE). For the fifth ... families with expert healthcare professionals and fellow patients to address ...
... , , , ... ) today announced that it has launched its newly updated online ... and motivated to live a healthier lifestyle. The free and open-to-everyone ... and other resources that allow people to share their experiences and ...
Cached Medicine News:Health News:105th APSA Meeting, world's largest for the study of politics, will be in Toronto Sept. 3-6 2Health News:KoolDocs.com Increases Online Presence through Social Networking Premium Online Medical Consultation Service Now on Facebook, Twitter, and LinkedIn 2Health News:Sagent Pharmaceuticals Announces Launch of Fluconazole Injection in Premix Ready-to-Use IV Bags 2Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 2Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 3Health News:Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy 4Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 2Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 3Health News:Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families 4Health News:Weight Watchers(R) Launches New Community on WeightWatchers.com 2Health News:Weight Watchers(R) Launches New Community on WeightWatchers.com 3
Disposable Lacrimal Dilators...
Fine & Medium Tapers....
Skin Tone External Eyelid Weights...
Contour Design Eyelid Implants....
Medicine Products: